Amazon Biotech to file FDA application for early-stage breast cancer drug

By Angela McDaniels

Seattle, Nov. 3 -Amazon Biotech Inc. said it is preparing an investigational new drug application for a drug candidate that may be useful in treating early-stage breast cancer.

Some of the active ingredients have shown anti-cancer efficacy during in vitro studies, the company said.

Amazon Biotech is a natural plant pharmaceutical company based in New York.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.